Monitoring Agency Report-30-06-2026

August 8, 2026 To, To, BSE Limited National Stock Exchange of India Limited PhirozeJeejeebhoy Towers, Exchange Plaza, Dalal Street, Mumbai- 400 001. Bandra Kurla Complex, Mumbai- 400 051. Scrip Code: 526729 Scrip Code: GOLDIAM EQ Dear Sir/Madam, Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to Regulation 32(6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 82(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018, please find enclosed herewith Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE Ratings Limited in respect of utilisation of funds raised through Qualified Institutions Placement (QIP). The same may please be taken on record and suitably disseminated to all concerned. Yours faithfully, For Goldiam International Limited Pankaj Parkhiya Company Secretary & Compliance Officer Encl.: As above Registered Office Gems & Jewellery Complex, Santacruz Electronics Export Processing Zone, Andheri (East), Mumbai-400096. India Phones: (022) 28291893/28290396/28292397 Fax : (022) 28292885 Email:- investorrelations@goldiam.com Website: www.goldiam.com Monitoring Agency Report No. CARE/HO/GEN/2026-2027/1124 The Board of Directors Goldiam International Limited Gems & Jewellery Complex, SEEPZ, Andheri East, Mumbai, Maharashtra- 400096 August 07, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Qualified Institutional Placement (QIP) of equity shares of Goldiam International Limited (“the Company”) We write in our capacity of Monitoring Agency for the qualified institutional placement (QIP) of equity shares for the amount aggregating to Rs. 202.05 crore of the Company and refer to our duties cast under Regulation 173A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 12, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Raunak Modi Assistant Director raunak.modi@careedge.in Report of the Monitoring Agency Name of the issuer: Goldiam International Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The Monitoring Agency (MA) does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Raunak Modi Designation of Authorized person/Signing Authority: Assistant Director 1) Issuer Details: Name of the issuer : Goldiam International Limited Name of the promoter : Rashesh Manhar Bhansali, Anmol Rashesh Bhansali, Shobhnaben Manharkumar Bhansali Industry/sector to which it belongs : Consumer Durables- Gems & Jewellery And Watches 2) Issue Details Issue Period : August 12, 2025 to August 18, 2025 Type of issue (public/rights) : Qualified Institutional Placement (QIP) Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 202.05 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of Directors preparation of report All issue proceeds utilised in Q1 FY27 are towards the objects The Company is specified in the placement document. wisely choosing to open stores in There is delay in utilization of proceeds as compared to profitable locations placement document and the company has taken approval on in malls across May 14, 2026, to extend the timeline for utilization of proceeds. India. Out of total net proceeds of Rs. 195.21 crore, the placement CA Certificate*, management document specifies timeline for deployment of Rs. 85.19 crore of declaration, placement document, issue proceeds as March 31, 2026, and balance till March 31, Board resolution dated August 11, 2025, Whether all utilization is as per the disclosures in the No management approval email for 2027. However, the company had utilised only Rs. 44.61 crore till Offer Document? June 30, 2026. The placement document states that the company investment of unutilized proceeds and could revise the funding requirement and intended deployment for extension of timeline dated May 13, schedule, including rescheduling or revising the planned 2026, and July 23, 2026 expenditure, implementation schedule and funding requirement, at the discretion of the management. The MA has received an email dated May 13, 2026, from the company’s compliance officer defining the management as the Executive Chairman, Managing Director, Company Secretary and CFO, severally. The MA has received an email dated May 14, 2026, from the Chairman Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of Directors preparation of report granting approval for the revision in timeline for the utilisation of funds till November 30, 2026 that were unutilised and originally estimated for FY26. The MA also notes that the company has opened 25 new retail stores till June 30, 2026, against planned 63 stores as per offer document. Also, MA notes that as per the placement document, the unutilized net proceeds can be invested in one or more scheduled commercial banks or temporarily invested in creditworthy instruments, including in money market instruments including money market/debt mutual funds, in accordance with applicable laws and other investments as approved by the Board of Directors. Company has taken required approval for investment of utilized proceeds in non-convertible de [Showing first 8,000 characters — download PDF for full document]